STARSCAPE-2 (EFC18327): A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Phase 3, Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants with Moderately to Severely Active Crohn's Disease